Demographic and Other Characteristics in Patients Enrolled With Polymerase Chain Reaction–Confirmed Severe Acute Respiratory Syndrome Coronavirus 2 Infection
| Patient Characteristics . | Overall (N = 111) . | Clinically Adjudicateda (n = 104) . | Bacterial Coinfection Absent (n = 86) . | Bacterial Coinfection Present (n = 18) . |
|---|---|---|---|---|
| Age, y, mean (SD) | 60.81 (16.99) | 61.55 (16.82) | 60.22 (17.55) | 67.89 (11.01) |
| Male sex | 54 (48.6) | 49 (47.1) | 41 (47.7) | 8 (44.4) |
| Race/ethnicity | ||||
| Asian | 6 (5.4) | 3 (2.9) | 3 (3.5) | 0 (0.0) |
| Black or African American | 2 (1.8) | 1 (1.0) | 1 (1.2) | 0 (0.0) |
| White | 102 (91.9) | 99 (95.2) | 81 (94.2) | 18 (100.0) |
| Latin American | 1 (0.9) | 1 (1.0) | 1 (1.2) | 0 (0.0) |
| Hospitalization | 108 (97.3) | 101 (97.1) | 83 (96.5) | 18 (100.0) |
| Length of hospital stay, d, mean (SD) | 11.78 (10.65) | 11.15 (9.10) | 10.23 (8.81) | 15.39 (9.44) |
| Patients receiving ICU-level careb | 14 (12.6) | 14 (13.5) | 6 (7.0) | 8 (44.4) |
| Deaths | 5 (4.5) | 5 (4.8) | 2 (2.3) | 3 (16.7) |
| ICU care and/or deaths | 16 (14.4) | 16 (15.4) | 8 (9.3) | 8 (44.4) |
| ICU admission, ICU-level care, and/or deaths | 21 (18.9) | 20 (19.2) | 12 (14.0) | 8 (44.4) |
| Underlying conditions | ||||
| Diabetes | 33 (29.7) | 32 (30.8) | 24 (27.9) | 8 (44.4) |
| Cardiovascular conditions | 55 (49.5) | 54 (51.9) | 43 (50.0) | 11 (61.1) |
| Pulmonary conditions | 15 (13.5) | 15 (14.4) | 13 (15.1) | 2 (11.1) |
| Renal insufficiency | 16 (14.5) | 16 (15.5) | 12 (14.1) | 4 (22.2) |
| Immunosuppression | 19 (17.1) | 18 (17.3) | 16 (18.6) | 2 (11.1) |
| Cancer | 10 (9.1) | 10 (9.7) | 10 (10.6) | 1 (5.6) |
| Patient Characteristics . | Overall (N = 111) . | Clinically Adjudicateda (n = 104) . | Bacterial Coinfection Absent (n = 86) . | Bacterial Coinfection Present (n = 18) . |
|---|---|---|---|---|
| Age, y, mean (SD) | 60.81 (16.99) | 61.55 (16.82) | 60.22 (17.55) | 67.89 (11.01) |
| Male sex | 54 (48.6) | 49 (47.1) | 41 (47.7) | 8 (44.4) |
| Race/ethnicity | ||||
| Asian | 6 (5.4) | 3 (2.9) | 3 (3.5) | 0 (0.0) |
| Black or African American | 2 (1.8) | 1 (1.0) | 1 (1.2) | 0 (0.0) |
| White | 102 (91.9) | 99 (95.2) | 81 (94.2) | 18 (100.0) |
| Latin American | 1 (0.9) | 1 (1.0) | 1 (1.2) | 0 (0.0) |
| Hospitalization | 108 (97.3) | 101 (97.1) | 83 (96.5) | 18 (100.0) |
| Length of hospital stay, d, mean (SD) | 11.78 (10.65) | 11.15 (9.10) | 10.23 (8.81) | 15.39 (9.44) |
| Patients receiving ICU-level careb | 14 (12.6) | 14 (13.5) | 6 (7.0) | 8 (44.4) |
| Deaths | 5 (4.5) | 5 (4.8) | 2 (2.3) | 3 (16.7) |
| ICU care and/or deaths | 16 (14.4) | 16 (15.4) | 8 (9.3) | 8 (44.4) |
| ICU admission, ICU-level care, and/or deaths | 21 (18.9) | 20 (19.2) | 12 (14.0) | 8 (44.4) |
| Underlying conditions | ||||
| Diabetes | 33 (29.7) | 32 (30.8) | 24 (27.9) | 8 (44.4) |
| Cardiovascular conditions | 55 (49.5) | 54 (51.9) | 43 (50.0) | 11 (61.1) |
| Pulmonary conditions | 15 (13.5) | 15 (14.4) | 13 (15.1) | 2 (11.1) |
| Renal insufficiency | 16 (14.5) | 16 (15.5) | 12 (14.1) | 4 (22.2) |
| Immunosuppression | 19 (17.1) | 18 (17.3) | 16 (18.6) | 2 (11.1) |
| Cancer | 10 (9.1) | 10 (9.7) | 10 (10.6) | 1 (5.6) |
Data are presented as No. (%) unless otherwise indicated.
Abbreviations: ICU, intensive care unit; SD, standard deviation.
Clinical adjudication was performed in 104 patients (7 patients lost to follow-up).
ICU-level care: receipt of vasopressors, mechanical ventilation, or renal replacement therapy.
Demographic and Other Characteristics in Patients Enrolled With Polymerase Chain Reaction–Confirmed Severe Acute Respiratory Syndrome Coronavirus 2 Infection
| Patient Characteristics . | Overall (N = 111) . | Clinically Adjudicateda (n = 104) . | Bacterial Coinfection Absent (n = 86) . | Bacterial Coinfection Present (n = 18) . |
|---|---|---|---|---|
| Age, y, mean (SD) | 60.81 (16.99) | 61.55 (16.82) | 60.22 (17.55) | 67.89 (11.01) |
| Male sex | 54 (48.6) | 49 (47.1) | 41 (47.7) | 8 (44.4) |
| Race/ethnicity | ||||
| Asian | 6 (5.4) | 3 (2.9) | 3 (3.5) | 0 (0.0) |
| Black or African American | 2 (1.8) | 1 (1.0) | 1 (1.2) | 0 (0.0) |
| White | 102 (91.9) | 99 (95.2) | 81 (94.2) | 18 (100.0) |
| Latin American | 1 (0.9) | 1 (1.0) | 1 (1.2) | 0 (0.0) |
| Hospitalization | 108 (97.3) | 101 (97.1) | 83 (96.5) | 18 (100.0) |
| Length of hospital stay, d, mean (SD) | 11.78 (10.65) | 11.15 (9.10) | 10.23 (8.81) | 15.39 (9.44) |
| Patients receiving ICU-level careb | 14 (12.6) | 14 (13.5) | 6 (7.0) | 8 (44.4) |
| Deaths | 5 (4.5) | 5 (4.8) | 2 (2.3) | 3 (16.7) |
| ICU care and/or deaths | 16 (14.4) | 16 (15.4) | 8 (9.3) | 8 (44.4) |
| ICU admission, ICU-level care, and/or deaths | 21 (18.9) | 20 (19.2) | 12 (14.0) | 8 (44.4) |
| Underlying conditions | ||||
| Diabetes | 33 (29.7) | 32 (30.8) | 24 (27.9) | 8 (44.4) |
| Cardiovascular conditions | 55 (49.5) | 54 (51.9) | 43 (50.0) | 11 (61.1) |
| Pulmonary conditions | 15 (13.5) | 15 (14.4) | 13 (15.1) | 2 (11.1) |
| Renal insufficiency | 16 (14.5) | 16 (15.5) | 12 (14.1) | 4 (22.2) |
| Immunosuppression | 19 (17.1) | 18 (17.3) | 16 (18.6) | 2 (11.1) |
| Cancer | 10 (9.1) | 10 (9.7) | 10 (10.6) | 1 (5.6) |
| Patient Characteristics . | Overall (N = 111) . | Clinically Adjudicateda (n = 104) . | Bacterial Coinfection Absent (n = 86) . | Bacterial Coinfection Present (n = 18) . |
|---|---|---|---|---|
| Age, y, mean (SD) | 60.81 (16.99) | 61.55 (16.82) | 60.22 (17.55) | 67.89 (11.01) |
| Male sex | 54 (48.6) | 49 (47.1) | 41 (47.7) | 8 (44.4) |
| Race/ethnicity | ||||
| Asian | 6 (5.4) | 3 (2.9) | 3 (3.5) | 0 (0.0) |
| Black or African American | 2 (1.8) | 1 (1.0) | 1 (1.2) | 0 (0.0) |
| White | 102 (91.9) | 99 (95.2) | 81 (94.2) | 18 (100.0) |
| Latin American | 1 (0.9) | 1 (1.0) | 1 (1.2) | 0 (0.0) |
| Hospitalization | 108 (97.3) | 101 (97.1) | 83 (96.5) | 18 (100.0) |
| Length of hospital stay, d, mean (SD) | 11.78 (10.65) | 11.15 (9.10) | 10.23 (8.81) | 15.39 (9.44) |
| Patients receiving ICU-level careb | 14 (12.6) | 14 (13.5) | 6 (7.0) | 8 (44.4) |
| Deaths | 5 (4.5) | 5 (4.8) | 2 (2.3) | 3 (16.7) |
| ICU care and/or deaths | 16 (14.4) | 16 (15.4) | 8 (9.3) | 8 (44.4) |
| ICU admission, ICU-level care, and/or deaths | 21 (18.9) | 20 (19.2) | 12 (14.0) | 8 (44.4) |
| Underlying conditions | ||||
| Diabetes | 33 (29.7) | 32 (30.8) | 24 (27.9) | 8 (44.4) |
| Cardiovascular conditions | 55 (49.5) | 54 (51.9) | 43 (50.0) | 11 (61.1) |
| Pulmonary conditions | 15 (13.5) | 15 (14.4) | 13 (15.1) | 2 (11.1) |
| Renal insufficiency | 16 (14.5) | 16 (15.5) | 12 (14.1) | 4 (22.2) |
| Immunosuppression | 19 (17.1) | 18 (17.3) | 16 (18.6) | 2 (11.1) |
| Cancer | 10 (9.1) | 10 (9.7) | 10 (10.6) | 1 (5.6) |
Data are presented as No. (%) unless otherwise indicated.
Abbreviations: ICU, intensive care unit; SD, standard deviation.
Clinical adjudication was performed in 104 patients (7 patients lost to follow-up).
ICU-level care: receipt of vasopressors, mechanical ventilation, or renal replacement therapy.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
